AmegA Sciences plc

Some 25 years ago, plant pathologists from the Research & Development Department of AmegA Sciences identified the organism responsible for the turfgrass disease known as Dry Patch. Within four years the company`s formulation chemists created the world`s first treatment for the disease, verified the product though extensive independent trials testing and introduced it to market. Continued research revealed the several different conditions in which the organism thrived and additional products were developed to deal with a wider variety of soil conditions and levels of disease severity. In addition, separate new products for the agricultural, horticultural and forestry markets were developed. Today, products formulated and manufactured by AmegA Sciences are used throughout Europe, North America and the Far East under a variety of distributor Own Labels.

Company details

7 Daimler Close, Royal Oak Industrial Estate, Daventry , Northants , NN11 8QJ United Kingdom

Locations Served

Business Type:
Distributor
Industry Type:
Agriculture
Market Focus:
Internationally (various countries)

Helping to Protect Against Hazardous Substances.

AmegA Sciences Plc is fully committed to REACH. We continue to manage and review our operations as well as the supply of our raw materials to ensure full compliance.

All products have been pre-registered during the pre-registration phase of the REACH regulations. Any required registrations will be complete by 2018. AmegA Sciences Plc does not have any 2013 obligations.

Image

AmegA Sciences is an experienced exporter with trusted partners in many regions of the world. AmegA Sciences transports many products by land, sea and air on a daily basis.  Our knowledgeable staff can offer full support in ensuring goods arrive on time and perfect condition. We work with a network of shipping and transport companies to offer great service and rates. Products can also be formulated and adapted to meet the specific demands of the local climate and conditions.

AmegA Sciences are a high quality manufacturer with a long established history of expertise in formulation chemistry. Quality control is an essential aspect of our processing and integral to this is a a fully equipped research and development laboratory and a quality assurance laboratory with HPLC analytical equipment. This is underlined by ISO 9001:2008 accreditation and the added assurance that programmes are overseen and managed by highly qualified scientists.

Batch productions are numbered and samples of each are kept for six months for traceability. Certificates of conformity and analysis can also be provided.

AmegA Sciences complement high quality contract processing with a flexible and efficient service designed to fit the individual requirements of our clients. In addition, AmegA Sciences offer research and development and quality control procedures to ensure products that meet your end users’ needs.

Our manufacturing includes:

  • Powder blending
  • Liquid formulation
  • Granule processing

in addition to packing and labelling, warehousing and distribution.

AmegA Sciences Plc is also accredited to BS EN ISO 13485:2012 which is a quality management system for regulatory purposes on medical devices.